Paper82206
Increased plasma protein binding of propranolol and chlorpromazine mediated by disease-induced elevations of plasma alpha1 acid glycoprotein.
Piafsky KM and 4 others. N Engl J Med, 1978. Cited by 355 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Increased plasma protein binding of propranolol and chlorpromazine mediated by disease-induced elevations of plasma alpha1 acid glycoprotein. Papers, record 82206. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/82206
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Increased plasma protein binding of propranolol and chlorpromazine mediated by disease-induced elevations of plasma alpha1 acid glycoprotein.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Chlorpromazine | Major topic |
| Disease | Major topic |
| Propranolol | Major topic |
| alpha-Macroglobulins | Major topic |
| Adult | |
| Aged | |
| Arthritis | |
| Crohn Disease | |
| Female | |
| Humans | |
| Kidney Failure, Chronic | |
| Male | |
| Middle Aged | |
| Protein Binding |
Source PubMed
Cited by100
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 355 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 34,071,813 | Therapeutic Drug Monitoring of Second- and Third-Generation Antipsychotic Drugs-Influence of Smoking Behavior and Inflammation on Pharmacokinetics. | Pharmaceuticals (Basel) | 2021 | https://conductscience.org/library/papers/34071813 | PubMed |
| 32,744,755 | Canine orosomucoid (alpha-1 acid glycoprotein) variants and their influence on drug plasma protein binding. | J Vet Pharmacol Ther | 2021 | https://conductscience.org/library/papers/32744755 | PubMed |
| 29,941,014 | Inflammation down-regulates CYP3A4-catalysed drug metabolism in hemodialysis patients. | BMC Pharmacol Toxicol | 2018 | https://conductscience.org/library/papers/29941014 | PubMed |
| 29,931,580 | A Semi-Physiologically Based Pharmacokinetic Model Describing the Altered Metabolism of Midazolam Due to Inflammation in Mice. | Pharm Res | 2018 | https://conductscience.org/library/papers/29931580 | PubMed |
| 29,510,250 | Characterization of solution-phase drug-protein interactions by ultrafast affinity extraction. | Methods | 2018 | https://conductscience.org/library/papers/29510250 | PubMed |
| 28,366,566 | Chromatographic studies of drug interactions with alpha1-acid glycoprotein by ultrafast affinity extraction and peak profiling. | J Chromatogr A | 2017 | https://conductscience.org/library/papers/28366566 | PubMed |
| 28,281,195 | Microdialysis: the Key to Physiologically Based Model Prediction of Human CNS Target Site Concentrations. | AAPS J | 2017 | https://conductscience.org/library/papers/28281195 | PubMed |
| 25,557,141 | Population pharmacokinetic model of free and total ropivacaine after transversus abdominis plane nerve block in patients undergoing liver resection. | Br J Clin Pharmacol | 2015 | https://conductscience.org/library/papers/25557141 | PubMed |
| 22,159,869 | Metabolism of alprazolam (a marker of CYP3A4) in hemodialysis patients with persistent inflammation. | Eur J Clin Pharmacol | 2012 | https://conductscience.org/library/papers/22159869 | PubMed |
| 22,134,720 | Orosomucoid serum concentrations and fat depot-specific mRNA and protein expression in humans. | Mol Cells | 2012 | https://conductscience.org/library/papers/22134720 | PubMed |
| 12,839,868 | Despite increased plasma concentration, inflammation reduces potency of calcium channel antagonists due to lower binding to the rat heart. | Br J Pharmacol | 2003 | https://conductscience.org/library/papers/12839868 | PubMed |
| 11,350,865 | Drug-disease interactions: reduced beta-adrenergic and potassium channel antagonist activities of sotalol in the presence of acute and chronic inflammatory conditions in the rat. | Br J Pharmacol | 2001 | https://conductscience.org/library/papers/11350865 | PubMed |
| 10,749,520 | Age-related changes in protein binding of drugs: implications for therapy. | Clin Pharmacokinet | 2000 | https://conductscience.org/library/papers/10749520 | PubMed |
| 8,748,391 | Influence of age, renal and liver impairment on the pharmacokinetics of risperidone in man. | Psychopharmacology (Berl) | 1995 | https://conductscience.org/library/papers/8748391 | PubMed |
| 8,359,187 | Plasma protein binding of the enantiomers of hydroxychloroquine and metabolites. | Eur J Clin Pharmacol | 1993 | https://conductscience.org/library/papers/8359187 | PubMed |
| 8,329,289 | The pharmacokinetics of remoxipride and metabolites in patients with various degrees of renal function. | Br J Clin Pharmacol | 1993 | https://conductscience.org/library/papers/8329289 | PubMed |
| 8,261,714 | Individual variation in first-pass metabolism. | Clin Pharmacokinet | 1993 | https://conductscience.org/library/papers/8261714 | PubMed |
| 7,461,027 | Comparison of the serum protein binding of maprotiline and phenytoin in uraemic patients on haemodialysis. | Eur J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/7461027 | PubMed |
| 7,378,264 | Increased plasma propranolol binding in myocardial infarction. | Br J Clin Pharmacol | 1980 | https://conductscience.org/library/papers/7378264 | PubMed |
| 7,378,256 | Blood plasma binding of acebutolol and diacetolol in man. | Br J Clin Pharmacol | 1980 | https://conductscience.org/library/papers/7378256 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/82206
GET https://conductscience.org/api/papers/v1/82206/cited_by?page=2